Cannabis Breathalyzer Moves Closer to Commercialization


Ryan Allway

July 26th, 2016

News, Top News


The legalization of recreational and medical marijuana has taken the United States and Canada by storm. While marijuana remains a Schedule I Controlled Substance on a federal level, the drug has been legalized for recreational use in five states and several others are set to vote in the U.S.’ November election to potentially follow suit. Many experts agree that California’s legalization measure, if approved, could be the tipping point needed for the federal government to take action.

The legalization of marijuana is widely seen as a net benefit to society, since it reduces incarceration rates, increases tax revenue, and helps fight organized crime. Of course, driving under the influence of marijuana remains a major concern for law enforcement. Unlike alcohol, there’s no easy test for THC – the psychoactive component of marijuana – that can be given roadside and those suspected must go through invasive blood testing.

In this article, we will take a look at Cannabix Technologies Inc. (OTC Pink: BLOZF, CSE: BLO) and its innovative marijuana breathalyzer that recently took a step closer to commercialization.

Closer to Reality

Cannabix Technologies’ marijuana breathalyzer leverages mass spectrometry to detect the presence of THC in breath samples. Of course, mass spec machines are not exactly known for their small size, since they must ionize samples and sort the ions based on their mass to charge ratio in order to identify components of the sample. The company has been diligently working to reduce the size of its mass spec technology to a roadside-friendly level.

The company is developing its mass spec technology in conjunction with the Yost Research Group – a global leader in high-field asymmetric waveform ion mobility spectrometry or FAIMS. According to Dr. Richard A. Yost, who heads up the Yost Research Group and teaches at the University of Florida, “FAIMS is a highly selective atmospheric-pressure separation technique that has the potential to provide a portable, field capability for the detection of THC.”

On July 25, the company announced the development of its beta version of the Cannabix Marijuana Breathalyzer. Cannabix has made significant inroads in recent months in reducing the overall size of its device. In particular, the FAIMS cell employed in the device is four times smaller than the prior benchtop version and has a 10x reduction in power supply requirements while maintaining the same THC sensitivity. This represents a key step forward in developing a mobile-friendly version of the breathalyzer that can be used for roadside testing.

Growing Market

The market for drug and alcohol testing is expected to grow at a 9.5% compound annual growth rate to reach $6.3 billion by 2019, according to Markets and Markets. Within the industry the analyst expects the breath sample segment to grow at the fastest CAGR, as it is the most common test performed for driving under the influence (DUI) cases. The market is dominated by North America and Europe, although the Asia-Pacific market is likely to see the fastest growth.

The greatest demand for marijuana breathalyzers will likely come from law enforcement, where there are few options to easily detect high drivers. But, another significant customer base may be employers who, for example, may want to screen heavy equipment operators. These groups must currently randomly screen individuals using more invasive urine or blood testing, which means that the tests cannot be performed very frequently.

Cannabix Technologies considers itself a first mover in the development of a marijuana breathalyzer, with its well-qualified founder – a retired Royal Canadian Mounted Police Officer – and its exclusive worldwide license to the University of Florida’s Patent 8,237,118 in the area of breath analysis of controlled substances, as well as its relationship with Dr. Yost.

Looking Ahead

Cannabix Technologies has made tremendous progress in bringing its marijuana breathalyzer closer to commercialization. With a tremendous market opportunity in its crosshairs, investors may want to keep a closer eye on a leader in the race to develop a functional breathalyzer for law enforcement, employers, and other end markets.

For more information, visit the company’s website at www.cannabixtechnologies.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Media Group (CannabisFN), owned and operated by CFN Enterprises Inc. (OTCQB: CNFN), is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading